Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies.

Indian Pacing Electrophysiol J · 2019 · PMC6450828 · PMID 30145313

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

As for voltage amplitude threshold, there was a highly significant increase over time equivalent to +0.48 Vms over 5 years (95% CI 0.24 to 0.71 Vms, p < 0.001) for DCM patients, while for ARVC patients there was no significant change (p = 0.249). 3.5.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.